GHTM

Global Health and Tropical Medicine

  • GHTM
    • About GHTM
    • Governance
    • Impact
    • Members
    • Scientific Advisory Board
    • Reports
      • GHTM
  • Research
    • Cross-cutting issues
      • Antimicrobial Resistance and Drug Discovery
      • Host–Pathogen Interactions
      • Genomic Surveillance and Population Mobility
      • Implementation and Translational Research
      • Information for Health Development
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • PRIME – Pathogen resistance, infection and molecular epidemiology
      • VBD – Vector borne diseases
      • CTM – Clinical tropical medicine
    • Research in numbers
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
      • Completed Projects
  • Outreach
    • Events
    • News
    • Policy Support & Community Outreach
  • Publications
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Capacity Building
    • Education
      • Master Theses
      • PhD Theses
    • International
  • Infrastructures
    • BIOHUB & Available Software
    • BIOTROP Biobank
    • VIASEF & Insectaries
  • Networks & Partnerships
Home / Archives for inesperiquito

GHTM Session | LABTROP – Common Laboratory Platform: Updates and New Implementation Processes

September 6, 2025

Discover the next steps for LABTROP implementation—join the session on 17 September at 11:00.
Read More

GHTM Session | Data Sources and Statistical analysis in Global Health: methodological opportunities from Demographic and Health surveys and Routinely-collected health Data

July 28, 2025

 Date: 31 July 2025  Time: 14:30-16:30  Location: ZOOM & Sala Cambournac | IHMT-NOVA The global health research landscape has been transformed by the growing number and volume of community surveys (CS) such as Demographic and Health Surveys (DHS). These data have been collected through coloboration between in country teams and Global Institutions such as USAID, […]
Read More

GHTM | IHMT-NOVA Professor Contributes to Landmark Study on Cancer-Causing Viruses

July 4, 2025

Professor Celso Cunha co-authors an IARC study confirming HDV and MCPyV as human carcinogens, advancing global research on virus-related cancers.
Read More

GHTM Session | Computer-Aided Drug Design to Combat Neglected Tropical Diseases and Other Infectious Diseases

July 1, 2025

On 29 July 2025, 14:00–16:00, explore innovative computer-aided drug design approaches targeting neglected tropical and other infectious diseases.
Read More

GHTM Session | Type I IFN activation in brain endothelium by Plasmodium-derived extracellular particles: implications for adjunctive treatments in cerebral malaria

July 1, 2025

On 16 July 2025 at 11:00, discover new insights into brain endothelial immunity and potential therapies for cerebral malaria in this GHTM session.
Read More

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 13
  • Next Page »

About GHTM

GHTM is a R&D Unit that brings together researchers with a track record in Tropical Medicine and International & Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal

+351 213 652 600

  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Funding

UID/04413/2025 - DOI: 10.54499/UID/04413/2025

UID/PRR/04413/2025 - DOI: 10.54499/UID/PRR/04413/2025

UID/PRR2/04413/2025 - DOI: 10.54499/UID/PRR2/04413/2025

  • Events
  • Research Groups
  • Cross-cutting issues
© Copyright 2026 IHMT-UNL All Rights Reserved.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    UIDB/04413/2020
    UIDP/04413/2020

Loading Comments...

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.